Frank McCormick Sells Shares in BridgeBio Pharma, Inc.

Frank McCormick, a director of BridgeBio Pharma, Inc., sold 1,641 shares of common stock on October 27, 2025, at a price of $65 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted on August 28, 2024. Following the sale, McCormick's direct ownership in the company stands at 83,275 shares, while his indirect ownership through the Francis P. McCormick Rev Trust U/A DTD 1/27/2017 is 878,338 shares. The filing highlights McCormick's continued significant stake in the company despite the sale.